Start Date
August 2, 2021
Primary Completion Date
October 22, 2021
Study Completion Date
October 22, 2021
Balstilimab (BAL)
Anti-PD-1 Monoclonal antibody
Topotecan
Chemotherapy
Vinorelbine
Chemotherapy
Gemcitabine
Chemotherapy
Irinotecan
Chemotherapy
Pemetrexed
Chemotherapy
Optimum Research (Southwest Women's Oncology Center), Albuquerque
Hematology Center after prof. R. Yeolyan, Yerevan
National Center of Oncology named after V.A. Fanarjian, Yerevan
Lead Sponsor
European Network of Gynaecological Oncological Trial Groups (ENGOT)
OTHER
Agenus Inc.
INDUSTRY